VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M, Degerman J, Nissinen TA, Miinalainen I, Kerkelä R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivelä R, Alitalo K.
Räsänen M, et al. Among authors: nissinen ta.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13144-13149. doi: 10.1073/pnas.1616168113. Epub 2016 Oct 31.
Proc Natl Acad Sci U S A. 2016.
PMID: 27799559
Free PMC article.